Perivine

CAS No. 2673-40-7

Perivine( —— )

Catalog No. M18335 CAS No. 2673-40-7

Perivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 104 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Perivine
  • Note
    Research use only, not for human use.
  • Brief Description
    Perivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy.
  • Description
    Perivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy. Perivine, vobasine, coronaridine and dichomine show hypotensive and muscle relaxant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2673-40-7
  • Formula Weight
    338.4
  • Molecular Formula
    C20H22N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC)C4[C@@H]3Cc1c(nc2ccccc12)C(=O)C[C@@H]4C(CN3)=[C@H]C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Huang H J, et al. Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.[J]. Biomed Research International, 2014, 2014(11):764946.
molnova catalog
related products
  • Valnoctamide

    Valnoctamide (Valmethamide) has antiepileptic and anticonvulsant activity and can be used in the study of neurological disorders.

  • Zeniplatin

    Zeniplatin (Zeniplatinum) is a new cisplatin complex with anticancer activity for the treatment of metastatic melanoma and kidney cancer.

  • HS271

    HS271 is a highly potent, orally active and selective IRAK4 inhibitor, with an IC50 of 7.2 μM. HS271 exhibits superior enzymatic and cellular activities, as well as excellent pharmacokinetic properties.